NIGERIAN-born researcher and medical doctor, Onyema Ogbuagu, has declared that he is not part of any conspiracy in the development of the COVID-19 vaccine.

Ogbuagu, who is an associate professor of Medicine at Yale University, is one of those leading the research at Pfizer for a possible COVID-19 vaccine in the United States.

Reacting to misconceptions about the vaccine, Ogbuagu said misinformation about the pandemic may lead to further loss of lives, adding that the efficacy of the vaccine is real.

“Let’s dispel some rumors especially because misinformation about COVID-19 may and can cost lives. Enough already! Vaccine efficacy results are real. They were not delayed hurting or help any politician. The Pfizer vaccine doesn’t contain the SARS CoV-2 virus or parts of it!

“No nefarious or sinister plan to inject people with a labeling code. The mRNA vaccine is not integrated into the recipient’s genome. No fetal tissue is used for the mRNA vaccine. And No!…researchers such as myself are not part of any conspiracies. We just want to apply science to improve patient outcomes and even better, to prevent disease.

“We can only work our way out of this pandemic through effective vaccines especially because it is difficult to achieve optimal mask-wearing and physical distancing to end the pandemic. Think of how vaccines have made deadly diseases either go away (smallpox) or become relatively rare (such as measles).

“When the “Covid-19” vaccine becomes available, let’s roll up our sleeves and let’s end this thing! Another challenge would be the equitable distribution of vaccines.

“High vs. low/middle-income countries, and even in developed nations, to ensure that vulnerable and underserved populations, disproportionally affected by the pandemic are proportionally reached! Now is time for strategic distribution plans at global, national and community level,” he explained.

This is a sequel to the announcement made by Pfizer and BioNTech stating that the first vaccine they developed against the pandemic could prevent more than 90 percent of people from getting infected, with Pfizer, saying it would be able to supply up to 50million doses by the end of 2020, and around 1.3billion by the end of next year.